“USE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY: CLINICAL EVIDENCE AND NUTRITIONAL IMPLICATIONS”. REMUNOM 21, no. 05 (December 28, 2025): 1–11. Accessed April 12, 2026. https://remunom.ojsbr.com/multidisciplinar/article/view/5181.